Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.24
Delayed Data
As of May 18
 +0.005 / +2.13%
Today’s Change
0.21
Today|||52-Week Range
0.68
-33.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues611.6K223.7K395.1K276.4K
 
 
 
 
 
Cost of Goods Sold0.000.003.7K318.00
 
 
 
Depreciation And Amortization70.5K50.3K56.9K38.0K
 
 
 
 
 
 
Operating ExpensesGross Income541.1K173.3K334.6K238.1K
 
 
 
 
 
General Expenses4.3M2.5M3.9M2.7M
 
 
 
 
 
Research And Development1.2M874.5K1.7M999.0K
 
 
 
 
 
Total Operating Expenses4.3M2.6M3.9M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.7M-2.4M-3.5M-2.5M
 
 
 
 
 
Extraordinary Credit12.9K0.0030.0K0.00
 
 
 
Extraordinary Charge-394.0K-35.0K-2.9M-4.3M
 
 
 
 
 
Interest Expense On Debt0.000.000.0044.0K
 
 
Other Expenses-722.7K-7.0K11.9K-4.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.8M-2.3M-6.4M-6.7M
 
 
 
 
 
Income Taxes-1.6M-775.8K-201.3K0.00
 
 
 
 
Minority Interest-33.00-23.00-18.00-9.00
 
 
 
 
 
Discontinued Operations-82.4K5.4K-157.9K0.00
 
 
 
 
Extraordinary Items-2.0M145.9K2.3M0.00
 
 
 
 
Net Income-3.2M-1.5M-6.3M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS161.9M162.0M162.1M162.3M
 
 
 
 
 
Shares To Calculate EPS Diluted161.9M162.0M162.1M162.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.01-$0.03-$0.04
 
 
 
 
 
EPS Diluted-$0.02-$0.01-$0.04-$0.04